A Study Evaluating Respiratory Causes Impacting Pilot Performance

Overview

About this study

The purpose of this study is to complete a series of three distinct tasks to address respiratory causes impacting pilot performance.

Task 1, entitled "Variable Oxygen Concentration Study," is to evaluate the three exposure variables through three study aims - differing on the oscillation frequency time windows or amplitude of the oxygen/nitrogen fluctuations.

The purpose of Task 2, entitled "The Cognitive Performance Cost of Increased Work of Breathing: Phase II," is to determine the impact of inspiratory and expiratory pressure-threshold loading on cognitive performance.

The purpose of Task 3, entitled "Causes of Decrements in Lung Physiology in High Performance Flight Operations," will be to understand the influence of various respiratory loads on development of decrements in lung physiology.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Between the ages of 18-50 years old.
  • Are of moderate to high fitness level and participate in regular physical activity.
  • Must have a body mass index (BMI) less than 31 kg/m^2.
  • Must be able to provide clear informed written consent.

Exclusion Criteria:

  • History of chronic respiratory, cardiovascular, metabolic disease or neural/cognitive disorders.
  • Anemia (< 12 g/dl for males, < 11 g/dl for females).
  • Migraines.
  • Active smoker (smoke within the past 6 years), or have more than 5 pack-years of smoking history
  • Females who are pregnant or trying to become pregnant.

Task 1 Specific:

  • History of pneumothorax, functionally limiting barotraumas or any inability to equalize tympanic pressure (e.g., during diving, swimming or flying).
  • Current dental abscesses or jaw pain consistent with severe dental caries.
  • Prior allergies or serious side effects from vasoconstrictors such as Afrin™ (oxymetazoline hydrochloride) utilized for sinus decongestion.
  • Hyperbaric exposure within the last 24 hours (for chamber visits).

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Bruce Johnson, Ph.D.

Open for enrollment

Contact information:

Briana Ziegler

(507)255-7125

Ziegler.Briana@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Bruce Johnson, Ph.D.

Open for enrollment

Contact information:

Jordan Parks B.S.

(480) 301-6616

Parks.Jordan@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20502615

Mayo Clinic Footer